127 related articles for article (PubMed ID: 37379957)
1. Design, synthesis and biological evaluation of nitric oxide-releasing 5-cyano-6-phenyl-2, 4-disubstituted pyrimidine derivatives.
Chi L; Wang H; Yu F; Gao C; Dai H; Si X; Dong Y; Liu H; Zhang Q
Bioorg Med Chem Lett; 2023 Aug; 92():129389. PubMed ID: 37379957
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Biological Evaluation of [1,2,4]Triazolo[1,5-
Yu GX; Hu Y; Zhang WX; Tian XY; Zhang SY; Zhang Y; Yuan S; Song J
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956943
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety.
Geng PF; Liu XQ; Zhao TQ; Wang CC; Li ZH; Zhang J; Wei HM; Hu B; Ma LY; Liu HM
Eur J Med Chem; 2018 Feb; 146():147-156. PubMed ID: 29407946
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents.
Lu CF; Wang SH; Pang XJ; Zhu T; Li HL; Li QR; Li QY; Gu YF; Mu ZY; Jin MJ; Li YR; Hu YY; Zhang YB; Song J; Zhang SY
Molecules; 2020 Nov; 25(23):. PubMed ID: 33255804
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
6. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents.
Li ZH; Yang DX; Geng PF; Zhang J; Wei HM; Hu B; Guo Q; Zhang XH; Guo WG; Zhao B; Yu B; Ma LY; Liu HM
Eur J Med Chem; 2016 Nov; 124():967-980. PubMed ID: 27771599
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antitumor activity evaluation of trifluoromethyl-substituted pyrimidine derivatives.
Liu L; Wang Z; Gao C; Dai H; Si X; Zhang Y; Meng Y; Zheng J; Ke Y; Liu H; Zhang Q
Bioorg Med Chem Lett; 2021 Nov; 51():128268. PubMed ID: 34302974
[TBL] [Abstract][Full Text] [Related]
9. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
10. Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies.
Zang Y; Huang L; Chen X; Li C; Ma J; Chen X; Zhang D; Lai F
Eur J Med Chem; 2022 Dec; 244():114832. PubMed ID: 36270090
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitors.
Wang R; Yu S; Zhao X; Chen Y; Yang B; Wu T; Hao C; Zhao D; Cheng M
Eur J Med Chem; 2020 Feb; 188():112024. PubMed ID: 31923858
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and preliminary biological evaluation of chrysin amino acid derivatives that induce apoptosis and suppress cell migration.
Liu YM; Li Y; Xiao J; Zhang QZ; Song JX
J Asian Nat Prod Res; 2020 Jun; 22(6):547-561. PubMed ID: 30938545
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents.
Ye T; Han Y; Wang R; Yan P; Chen S; Hou Y; Zhao Y
Bioorg Chem; 2020 Jun; 99():103796. PubMed ID: 32283346
[TBL] [Abstract][Full Text] [Related]
14. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
Shi JB; Tang WJ; Qi XB; Li R; Liu XH
Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
[TBL] [Abstract][Full Text] [Related]
15. Discovery of [1,2,4]triazolo[1,5-a]pyrimidines derivatives as potential anticancer agents.
Huo JL; Wang S; Yuan XH; Yu B; Zhao W; Liu HM
Eur J Med Chem; 2021 Feb; 211():113108. PubMed ID: 33385852
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, ADMET prediction and reverse screening study of 3,4,5-trimethoxy phenyl ring pendant sulfur-containing cyanopyrimidine derivatives as promising apoptosis inducing anticancer agents.
Nainwal LM; Shaququzzaman M; Akhter M; Husain A; Parvez S; Khan F; Naematullah M; Alam MM
Bioorg Chem; 2020 Nov; 104():104282. PubMed ID: 33010624
[TBL] [Abstract][Full Text] [Related]
17. Novel quinoline derivatives carrying nitrones/oximes nitric oxide donors: Design, synthesis, antiproliferative and caspase-3 activation activities.
Abdelbaset MS; Abdel-Aziz M; Abuo-Rahma GEA; Abdelrahman MH; Ramadan M; Youssif BGM
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800270. PubMed ID: 30500087
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of harmine-nitric oxide donor derivatives as potential antitumor agents.
Li Z; Apizi Y; Zhang C; Wang Z; He H; Li X; Zhu Y; Yang J; Xiao L; Wang M
Bioorg Med Chem Lett; 2022 Jun; 65():128698. PubMed ID: 35341920
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and preliminary biological evaluation of 5,8-dihydropteridine-6,7-diones that induce apoptosis and suppress cell migration.
Geng PF; Wang CC; Li ZH; Hu XN; Zhao TQ; Fu DJ; Zhao B; Yu B; Liu HM
Eur J Med Chem; 2018 Jan; 143():1959-1967. PubMed ID: 29133051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]